# Perioperative Respiratory Adverse events_sugammadex

> **NCT05354466** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 174 (actual)

## Conditions studied

- Respiratory Complication

## Interventions

- **DRUG:** Sugammadex injection
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT05354466
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-27
- **Primary completion:** 2024-09-04
- **Final completion:** 2024-09-04
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354466, "Perioperative Respiratory Adverse events_sugammadex". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05354466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*